NCT07146815Completed
PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease
Source: ClinicalTrials.gov · Last updated 28 Aug 2025
Brief summary (registry, in English)
To study the prevalence, non-invasive diagnostics and evolution of non-alcoholic-fatty-liver-disease (NAFLD) in patients with polycystic ovary syndrome (PCOS)
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 157 (actual)
- First submitted
- 29 Jul 2025
- Start date
- 29 Nov 2022
- Primary completion date
- 1 Apr 2025
- Lead sponsor
- Ziekenhuis Oost-Limburg
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07146815
What you commit to
- Study type: Interventional
- Participants enrolled: 157
- From 29 Nov 2022 to the primary completion date, 1 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Exclusion of other causes of liver disease
- Other causes of endocrinological disease
- Diseases that might mimic PCOS
Other
- Excessive alcohol use: ≥ 2u (20g)/day for females
- Secondary causes of liver steatosis
Who the study is looking for
- Adults (i.e. older than 18 years of age)
- The diagnosis of PCOS based on expert opinion (i.e. according to Rotterdam criteria)
- Able to understand patients information concerning this study
- Able to give written informed consent
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ziekenhuis Oost-Limburg Coordinator of this site? Confirm its status | Genk | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.